http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102106991-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-334 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S514-893 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-122 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-122 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-10 |
| filingDate | 2019-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2020-05-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2020-05-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-102106991-B1 |
| titleOfInvention | Therapeutic and preventive effect of astaxanthin in ethanol-induced liver injury |
| abstract | The present invention contains astaxanthin (ASX, 3,3'-dihydroxy-β, β'-carotene-4,4'-dione) as an active ingredient, which is effective in treating, preventing and alleviating alcoholic liver disease. It relates to a pharmaceutical composition or a food composition for the treatment or prevention of alcoholic liver disease, and more specifically, to inhibit inflammatory cytokine production by inhibiting the activity of STAT3 by binding to STAT3 and inhibit oxidative stress caused by ROS to alcoholic liver disease. It relates to a pharmaceutical composition or a food composition for the treatment or prevention of alcoholic liver disease exhibiting a prophylactic or therapeutic effect against. |
| priorityDate | 2019-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 310.